Health / Medical Topics

    Nadolol

    A non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities. Nadolol competitively blocks beta-1 adrenergic receptors located in the heart and vascular smooth muscle, inhibiting the activities of the catecholamines epinephrine and norepinephrine and producing negative inotropic and chronotropic effects. This agent exhibits antiarrhythmic activity via the impairment of atrioventricular (AV) node conduction and a corresponding reduction in sinus rate. In the kidney, inhibition of the beta-2 receptor within the juxtaglomerular apparatus results in the inhibition of renin production and a subsequent reduction in angiotensin II and aldosterone levels, thus inhibiting angiotensin II-dependent vasoconstriction and aldosterone-dependent water retention. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A wild-type zebrafish line, the stock of which was obtained from an area east of Calcutta in a district called Nadia. …
    A rare metabolic disorder characterized by the deficiency of mitochondrial NADH dehydrogenase component of complex I. Signs and symptoms include cardiomyopathy, encephalopathy,…
    NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (464 aa, ~51 kDa) is encoded by the human NDUFV1 gene. This protein plays a role…
    NAD(P)H-hydrate epimerase (288 aa, ~32 kDa) is encoded by the human APOA1BP gene. This protein is involved in both lipoprotein binding and…
    NAD(P)H dehydrogenase [quinone] 1 (274 aa, ~31 kDa) is encoded by the human NQO1 gene. This protein is involved in hydroquinone…
    NAD-dependent protein deacetylase sirtuin-7 (400 aa, ~45 kDa) is encoded by the human SIRT7 gene. This protein plays a role in protein…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact